BIONEER Corporation is the first Korean biotech company established in 1992. We have over 29 years of experience in R&D with more than 440 patents worldwide. BIONEER Corporation is the only company that has developed MDx systems and diagnostic kits with our innovation. We have numerous proprietary technology and developmental capability to venture into the MDx market. We have developed various products from automated instruments, including nucleic acid extractor, Real-Time PCR, MDx workstations, and MDx kits such as COVID-19, HIV, Hepatitis, STI, TB, ZIKV, RV tests, and many more.
AccuPower® RV1 Kit is for simultaneous diagnosis of COVID-19 and influenza. COVID-19 has some symptoms in common with the seasonal flu but their causes and treatments are different. Therefore, it is essential to distinguish between COVID-19 and flu to give appropriate treatment and preventive measures. AccuPower® RV1 Kit provides an optimal solution to deliver accurate and fast results to patients. This kit is for simultaneous detection of five targets, COVID-19 (E gene, RdRp/N gene) & Influenza A and B. Vacuum-dried Premix and Master-mix kits are available depending on the user's lab conditions. AccuPower® RV1 Real-Time RT-PCR kit (Vacuum-dried Premix) is compatible with our ExiStation™ series, a fully automated molecular diagnostic system with high specificity results with minimized cross-contamination and human error. AccuPower® RV1 Multiplex Kit (Mastermix) is compatible with a broad range of Real-Time PCR instruments including our Exicycler™96 for user convenience.
ExiPrep™ 96 Lite is an automated nucleic acid extractor with high capacity. It has built-in protocols optimized for various kit applications for the extraction of nucleic acid. The kit is compatible with the ExiPrep™ 96 Lite, and it provides the user convenience with the available pre-filled cartridges. ExiPrep™ 96 Lite can extract viral RNA in 30 minutes with Protonion™ Viral RNA Kit, which does not contain EtOH to prevent PCR inhibition and rapid extraction speed.